BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD
98 results:

  • 1. Development and validation of a clinical and ultrasound features-based nomogram for preoperative differentiation of renal urothelial carcinoma and central renal cell carcinoma.
    Li C; Lu B; Zhao Q; Lu Q; Wang J; Sun P; Xu H; Huang B
    World J Urol; 2024 Apr; 42(1):227. PubMed ID: 38598055
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular pathological approach to cancer epigenomics and its clinical application.
    Kanai Y
    Pathol Int; 2024 Apr; 74(4):167-186. PubMed ID: 38482965
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Married Status Affects Rates of Treatment and Mortality in Male and Female Renal Cell Carcinoma Patients Across all Stages.
    Siech C; Morra S; Scheipner L; Baudo A; Jannello LMI; de Angelis M; Goyal JA; Tian Z; Saad F; Shariat SF; Longo N; Carmignani L; de Cobelli O; Ahyai S; Briganti A; Mandel P; Kluth LA; Chun FKH; Karakiewicz PI
    Clin Genitourin Cancer; 2024 Apr; 22(2):593-598. PubMed ID: 38369387
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Predictive Model of CK7 Expression in Patients With Clear Cell Renal Cell Carcinoma by Combined Multimodal Ultrasound Diagnostic Techniques: A Retrospective Study.
    Zhu YF; Liu ML; Zheng WT; Fu F; Xue ES; Fan XQ; Zhang HP; Lian GT; Ye Q
    Ultrasound Med Biol; 2024 Apr; 50(4):520-527. PubMed ID: 38281886
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Costs of Cancer Prevention: Physical and Psychosocial Sequelae of Risk-Reducing Total Gastrectomy.
    Gallanis AF; Gamble LA; Samaranayake SG; Lopez R; Rhodes A; Rajasimhan S; Fasaye GA; Juma O; Connolly M; Joyce S; Berger A; Heller T; Blakely AM; Hernandez JM; Davis JL
    J Clin Oncol; 2024 Feb; 42(4):421-430. PubMed ID: 37903316
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Development and validation of a prognostic model for patients with sepsis in intensive care unit].
    Jiang Z; Wang H; Wang S; Guan C; Qu Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):800-806. PubMed ID: 37593856
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Six-transmembrane epithelial antigen of prostate 3 (STEAP3) is a potential prognostic biomarker in clear cell renal cell carcinoma that correlates with M2 macrophage infiltration and epithelial-mesenchymal.
    Wei H; Li Z; Zhao Y; Zhu S; Wen S; Quan C
    Cancer Rep (Hoboken); 2023 Aug; 6(8):e1824. PubMed ID: 37344930
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Laparoscopic Radical Nephrectomy with Transperitoneal Approach for Large Renal tumors: Standardized Surgical Technique and Outcomes.
    Peltrini R; Iacone B; Pacella D; Ilardi M; Sannino D; Tedesco A; Gargiulo A; Martirani M; Bracale U; Corcione F
    J Laparoendosc Adv Surg Tech A; 2023 Sep; 33(9):879-883. PubMed ID: 37262180
    [No Abstract]    [Full Text] [Related]  

  • 9. Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.
    Schmeusser BN; Midenberg E; Palacios AR; Ali AA; Patil DH; Higgins M; Nabavizadeh R; Croll B; Williams M; Sheehy J; Zheng B; Narayan VM; Joshi SS; Ogan K; Psutka SP; Bilen MA; Master VA
    Clin Genitourin Cancer; 2023 Aug; 21(4):475-482.e4. PubMed ID: 37210313
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. HIGD1A inactivated by DNA hypermethylation promotes invasion of kidney renal clear cell carcinoma.
    Li L; Zhao J; Zhang H; Li D; Wu S; Xu W; Pan X; Hu W; Chu J; Luo W; Li P; Zhou X
    Pathol Res Pract; 2023 May; 245():154463. PubMed ID: 37086631
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study.
    Asif B; Sarvestani AL; Gamble LA; Samaranayake SG; Famiglietti AL; Fasaye GA; Quezado M; Miettinen M; Korman L; Koh C; Heller T; Davis JL
    Lancet Oncol; 2023 Apr; 24(4):383-391. PubMed ID: 36990610
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Effects of miR-9-5p on the migration, invasion and epithelial-mesenchymal transition process in cervical squamous cell carcinoma.
    Kuang T; Li L; Chen Y; Wang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 48(1):15-23. PubMed ID: 36935173
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Deep learning-based decision forest for hereditary clear cell renal cell carcinoma segmentation on MRI.
    Lay N; Anari PY; Chaurasia A; Firouzabadi FD; Harmon S; Turkbey E; Gautam R; Samimi S; Merino MJ; Ball MW; Linehan WM; Turkbey B; Malayeri AA
    Med Phys; 2023 Aug; 50(8):5020-5029. PubMed ID: 36855860
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. SATB2 as a Marker of the Proximal Nephron: Expression in Nephrogenic Adenoma and Correlation With Other Renal Tubular Markers.
    Ortiz-Rey JA; Álvarez-Sarria M; Conde-Ferreirós M; Morellón-Baquera R; Bellas-Pereira A; Baltazar ST; García-Acuña S; San-Miguel Fraile P; Suárez-Peñaranda JM; Fernández-Baltar C; Vieytes-Molares M; Domínguez-Arístegui P; Gómez-de María C; Fachal-Bermúdez C; González-Carreró J
    Appl Immunohistochem Mol Morphol; 2023 Mar; 31(3):145-153. PubMed ID: 36744623
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A retrospective single-centered, comprehensive targeted genetic sequencing analysis of prognostic survival using tissues from Korean patients with metastatic renal cell carcinoma after targeted therapy.
    Kim SH; Park J; Park WS; Hong D; Chung J
    Investig Clin Urol; 2022 Nov; 63(6):602-611. PubMed ID: 36347549
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Aberrant inactivation of SCNN1G promotes the motility of head and neck squamous cell carcinoma.
    Yang Y; Zhong X; Lan Y; Liang P; Huang Y; Wang Y; Zhou X; Zhang Z; Liang Y; Xiao X
    Pathol Res Pract; 2022 Dec; 240():154175. PubMed ID: 36327816
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Interstitial Brachytherapy of the Liver for Renal Cell Carcinoma: ADC Measurements Do Not Predict Overall Survival.
    Thormann M; Heitmann F; Wrobel V; March C; Pech M; Surov A; Damm R; Omari J
    In Vivo; 2022; 36(6):2945-2951. PubMed ID: 36309358
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The potential key genes and pathways associated with Wilms tumor in quest of proper candidates for diagnostic and therapeutic purposes.
    Bitaraf M; Mahmanzar M; Zafari N; Mohammadpour H; Vasei M; Moradi Matin L; Kajbafzadeh AM; Majidi Zolbin M
    Sci Rep; 2022 Oct; 12(1):17906. PubMed ID: 36284226
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
    Sahu DK; Singh N; Das M; Rawat J; Gupta DK
    Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Outcome of Repeated Resection of Pulmonary Metastases for Renal Cell Cancer.
    Hassan M; Ehle B; Le UT; Titze L; Passlick B; Grapatsas K
    Thorac Cardiovasc Surg; 2023 Mar; 71(2):130-137. PubMed ID: 35987192
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.